CA2176145A1 - Implants oculaires biocompatibles - Google Patents

Implants oculaires biocompatibles

Info

Publication number
CA2176145A1
CA2176145A1 CA002176145A CA2176145A CA2176145A1 CA 2176145 A1 CA2176145 A1 CA 2176145A1 CA 002176145 A CA002176145 A CA 002176145A CA 2176145 A CA2176145 A CA 2176145A CA 2176145 A1 CA2176145 A1 CA 2176145A1
Authority
CA
Canada
Prior art keywords
ocular implants
administration
implants
biocompatible ocular
biocompatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002176145A
Other languages
English (en)
Other versions
CA2176145C (fr
Inventor
Vernon G. Wong
Frank Kochinke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/153,184 external-priority patent/US5443505A/en
Application filed by Individual filed Critical Individual
Publication of CA2176145A1 publication Critical patent/CA2176145A1/fr
Application granted granted Critical
Publication of CA2176145C publication Critical patent/CA2176145C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
CA002176145A 1993-11-15 1994-11-09 Implants oculaires biocompatibles Expired - Lifetime CA2176145C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/153,184 US5443505A (en) 1993-11-15 1993-11-15 Biocompatible ocular implants
US08/153,184 1993-11-15
PCT/US1994/012898 WO1995013765A1 (fr) 1993-11-15 1994-11-09 Implants oculaires biocompatibles

Publications (2)

Publication Number Publication Date
CA2176145A1 true CA2176145A1 (fr) 1995-05-26
CA2176145C CA2176145C (fr) 2007-04-10

Family

ID=38007156

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002176145A Expired - Lifetime CA2176145C (fr) 1993-11-15 1994-11-09 Implants oculaires biocompatibles

Country Status (1)

Country Link
CA (1) CA2176145C (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US11690807B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US12108225B2 (en) 2018-05-24 2024-10-01 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US12472148B2 (en) 2021-04-26 2025-11-18 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US11690807B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US11951215B2 (en) 2018-05-24 2024-04-09 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US12108225B2 (en) 2018-05-24 2024-10-01 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US12502360B2 (en) 2018-05-24 2025-12-23 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US12472148B2 (en) 2021-04-26 2025-11-18 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Also Published As

Publication number Publication date
CA2176145C (fr) 2007-04-10

Similar Documents

Publication Publication Date Title
TW368411B (en) Biocompatible ocular implants
CA2030459A1 (fr) Implants oculaires biodegradables
EP0322319A3 (en) Composition comprising biodegradable ocular implants
USD361555S (en) Combined programmer and monitor for an implantable tissue growth stimulator
AU5219693A (en) Medical implants of biocompatible low modulus titanium alloy
CA2294921A1 (fr) Levobupivacine et son utilisation
EE9700286A (et) Miootiliste ja müdriaatiliste ravimite kontrollitav vabanemine silma eeskambris
GB2264640B (en) Microcrystalline cellulose spheroids comprising hydromorphone and a sugar
FR2739783B1 (fr) Dispositif medical du type defibrillateur/cardioverteur implantable actif a defibrillation de l'oreillette
EP1676579A3 (fr) Utlisation de tetracyclines sub-microbiennes pour le traitement de la keratite rosacee
AU4111093A (en) Subconjunctival implants for ocular drug delivery
CA2111193A1 (fr) Composition comprenant de la fibrine ou du fibrinogene et un polymere biodegradable et biocompatible utilise pour traiter les tissus
CA2233043A1 (fr) Corps de chambre d'injection de medicaments
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
TW234691B (fr)
CA2154103A1 (fr) Traitement des maladies, traumatismes ou troubles de la membrane muqueuse, et pour le soulagement de la douleur
WO2003015667A8 (fr) Methode et implant intra-scleral pour le traitement du glaucome et de la presbyopie
CA2190303A1 (fr) Composition pharmaceutique; methode et dispositif pour prevenir ou traiter le syndrome sec ou les maladies qui en decoulent
EP0431074A4 (en) Disinfecting blood constituents, corneal and scleral tissue
EP0429522A4 (en) Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
CA2176145A1 (fr) Implants oculaires biocompatibles
USD353889S (en) Implantable tissue growth stimulator
CA2091134A1 (fr) Agent therapeutique contre les risques d'avortement
CA2228266A1 (fr) Utilisation de la l-cartinine et de ses derives dans le but de reduire les niveaux de ceramides et de potentialiser l'effet antiretroviral
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20141110